Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lyanne Oblein"'
Autor:
Chun-Hao Pan, Nina V. Chaika, Robert Tseng, Md Afjalus Siraj, Bo Chen, Katie L. Donnelly, Michael Horowitz, Cindy V. Leiton, Sumedha Chowdhury, Lucia Roa-Peña, Lyanne Oblein, Natalia Marchenko, Pankaj K. Singh, Kenneth R. Shroyer, Luisa F. Escobar-Hoyos
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer death. We previously reported keratin 17 (K17) as a novel negative prognostic and predictive biomarker, whose overexpression confers the resistance to chemotherapies. Here, we inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d002d9a6fbec605b5feca82f797c244
https://doi.org/10.1101/2022.08.24.504873
https://doi.org/10.1101/2022.08.24.504873
Autor:
Michael Horowitz, Lyanne Oblein, Jaymie Oentoro, Saumya Kasliwal, Natalia D. Marchenko, Luisa F. Escobar-Hoyos, Kenneth R. Shroyer
Publikováno v:
Cancer Research. 82:B049-B049
Background: Clinically and histologically identical pancreatic ductal adenocarcinomas (PDACs) differ in response to treatment, disease progression, and survival. Clinical trials are testing the use of either keratin 17 (K17) or GATA6 as surrogate pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7646bfb384fefa29c78ec20448052523
https://doi.org/10.1158/1538-7445.panca22-b049
https://doi.org/10.1158/1538-7445.panca22-b049
Autor:
Lyanne Oblein, Lucia Roa-Peña, Sruthi Babu, Felicia D. Allard, Natalia D. Marchenko, Luisa F. Escobar-Hoyos, Kenneth R. Shroyer
Publikováno v:
Cancer Research. 82:A042-A042
Background: There is an urgent need to understand why patients with clinically and histologically identical pancreatic ductal adenocarcinomas (PDACs) differ in response to treatment, disease progression, and survival. Although two standard chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0745a0eb4c1ae7cee06cff6555bc9865
https://doi.org/10.1158/1538-7445.panca22-a042
https://doi.org/10.1158/1538-7445.panca22-a042
Autor:
Lyanne Oblein, Michael Horowitz, Mahmudul Hasan, Sruthi Babu, Mariana Torrente-Goncalves, Lucia Roa, Jaymie Oentoro, Jason Harper, Xin Yao Zheng, Wei Jiang, Andrew Hendifar, Natalie Moshayedi, Brent Larson, Veronica Placencio-Hickok, Edik Blais, Emmanuel Petricoin, Joel Saltz, Natalia D. Marchenko, Luisa F. Escobar-Hoyos, Kenneth Shroyer
Publikováno v:
Cancer Research. 82:C071-C071
Background: Keratin 17 (K17) is a negative prognostic biomarker, overexpressed in the biologically most aggressive forms of pancreatic ductal adenocarcinoma (PDAC). In other anatomic sites and disease processes, K17 expression also correlates with im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50898d35d102e932c202870c67f76079
https://doi.org/10.1158/1538-7445.panca22-c071
https://doi.org/10.1158/1538-7445.panca22-c071
Autor:
Lyanne Oblein, Kenneth R. Shroyer, Sruthi Babu, Ali Akalin, Rajarsi Gupta, Luisa F. Escobar-Hoyos, Kester Haye
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 29(2)
The major roles of keratin 17 (K17) as a prognostic biomarker have been highlighted in a range of human malignancies. However, its relevance to esophageal squamous cell carcinoma (ESCC) remains unexplored. In this study, the relationship between K17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5debc22ca33caa60ff94330f444ecad
https://pubmed.ncbi.nlm.nih.gov/32554975
https://pubmed.ncbi.nlm.nih.gov/32554975